Approved for PIQRAY is indicated in combination with fulvestrant for the treatment of adults with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, PIK3CA-mutated, advanced or metastatic breast cancer as detected by an FDA-approved test following progression on or after an endocrine-based regimen.. Alpelisib is an inhibitor of phosphatidylinositol-3-kinase…
Loading full data from Know Your Drugs Institute…